CN105906591A - Synthesis method of 2-amino-gamma-butyrolactone hydrochloride - Google Patents

Synthesis method of 2-amino-gamma-butyrolactone hydrochloride Download PDF

Info

Publication number
CN105906591A
CN105906591A CN201610268551.5A CN201610268551A CN105906591A CN 105906591 A CN105906591 A CN 105906591A CN 201610268551 A CN201610268551 A CN 201610268551A CN 105906591 A CN105906591 A CN 105906591A
Authority
CN
China
Prior art keywords
benzyl
phenyl
base
valeryl
butyryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610268551.5A
Other languages
Chinese (zh)
Inventor
张大永
肖伟
周欣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Pharmaceutical University
Original Assignee
China Pharmaceutical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Pharmaceutical University filed Critical China Pharmaceutical University
Priority to CN201610268551.5A priority Critical patent/CN105906591A/en
Publication of CN105906591A publication Critical patent/CN105906591A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a synthesis method of 2-amino-gamma-butyrolactone hydrochloride (I) for a kind of important chemical, dye, pesticide and medical intermediates. The synthesis method includes the following steps: taking a gamma-butyrolactone compound (II) and a nitroso ester compound (III) as raw materials to react with each other to obtain 2-(hydroxyl imino)-gamma-butyrolactone (IV), and subjecting the compound (IV) to reduction reaction and acidification to obtain the 2-amino-gamma-butyrolactone hydrochloride (I). The method used for preparing the product compound (I) is mild in condition, simple to operate, high in yield, low in environmental pollution, easier for industrial production and the like.

Description

The synthesis of 2-amino-gamma-butyrolacton class hydrochlorate
Technical field
The present invention relates to the preparation method of glufosinate-ammonium intermediate, particularly relate to 2-amino-gamma-butyrolacton hydrochlorate (I) The new preparation method of preparation method.
Technical background
2-amino-gamma-butyrolacton hydrochlorate (I) can be as the key intermediate of glufosinate-ammonium synthesis.Glufosinate-ammonium was 20th century A kind of herbicide that first eighties is produced by Heochst company of Germany.It has that anti-grass spectrum is wide, low toxicity, efficient, non-selective Etc. advantage, it it is a kind of organic phosphates steriland herbicide with part systemic action.
Three big herbicide kinds are glyphosate, N,N'-dimethyl-.gamma..gamma.'-dipyridylium and glufosinate-ammonium the most in the world.Large area, big due to glyphosate Amount is reused, and the resistance problem already leading to weeds is difficult to solve.And it is only second to the world's second largest herbicide hundred of glyphosate Grass is withered, because causing the most unproductive being poisoned to death and not having antidote, N,N'-dimethyl-.gamma..gamma.'-dipyridylium will exit city in 1 day July in 2016 ?.So glufosinate-ammonium just obtains huge development space.The advantage such as the strong activity of weeding of glufosinate-ammonium, broad weed-killing spectrum, poisoning are little and The extensively plantation of glufosinate-resistant transgenic crop makes this kind generation of glufosinate-ammonium be attracted attention.But owing to technique, environmental protection etc. are asked Topic puzzlement, the production capacity of China's glufosinate-ammonium remains in about 1000 tons, does not has the company of large-scale production glufosinate-ammonium.
Most manufacturers all use Strecker method to synthesize glufosinate-ammonium.Strecker method technical maturity, Reaction condition is less demanding, and yield can reach about 35%.This route conditions is gentle, stable yield, is the most ripe One of glufosinate-ammonium route.But, this method inevitably to use severe toxicity cyanide, gives to produce and causes potential safety with environment Threaten.At present agriculture chemical registration just towards efficient, high-load, low toxicity, noresidue, without security risk, without environmental risk, nothing use wind Direction, danger is developed.So how get around Strecker method, propose that a kind of route is short, yield is high, safety is high, it is little to pollute, be suitable for The preparation method of industrialized production glufosinate-ammonium is significant.
There are reports for the method for synthesis 2-amino-gamma-butyrolacton hydrochlorate (I), (Koch, Troels; Buchardt, Ole.Synthesis, 1993,11,1065-1067): it is raw material with methionine, obtains through three steps synthesis.
Document report yield 60%, this route cost is the highest, and the response time is the longest and introduces poisonous reagent iodomethane, it is difficult to Detection reaction process.
Summary of the invention
The invention provides one and prepare the new method of 2-amino-gamma-butyrolacton class hydrochlorate (I), use this law to prepare Product I, not only mild condition, simple to operate, yield is high, and it is little to have environmental pollution, is more easy to realize industrialized production etc. Advantage.As the intermediate of glufosinate-ammonium synthesis, this law effectively avoids the extremely toxic substances such as cyanide, the industrialization to glufosinate-ammonium Production has reference value.
The method preparing 2-amino-gamma-butyrolacton class hydrochlorate (I) that the present invention provides, is divided into following steps:
(1) with gamma-butyrolacton compounds (II) and nitrite compounds (III) as raw material, it is dissolved in organic solvent, Add alkali, obtain 2-(oxyimino)-gamma-butyrolacton (IV) in-70 DEG C-25 DEG C reaction 1-6h.Gamma-butyrolacton compounds (II) mol ratio with nitrite compounds (III) is 1: 0.5~1: 1.5, preferably 1: 1~1.2;Reactant II and alkali Mol ratio be 1: 0.5~1: 2.5, preferably 1: 1.2~1.5.
R1 structure representation is: H, substituted or non-substituted straight chain, side chain or ring-type alkyl, phenyl, benzyl, Wherein m=1~8.Above-mentioned straight chain, side chain or ring-type alkyl can tables further State as (1) C1~C10Alkyl: methyl, ethyl, propyl group, isopropyl, normal-butyl, isobutyl group, the tert-butyl group, sec-butyl, amyl group, new Amyl group, hexyl, heptyl, octyl group;(2)C3~C10Cycloalkyl: cyclopropyl, cyclobutyl, cyclopenta, cyclohexyl;(3)C3~C10Alkene Base: pi-allyl, cyclobutenyl, crotyl, pentenyl, pentenyl, 3-pentenyl;(4)C3~C10Alkynyl: propinyl, butine Base, 2-butyne base, pentynyl, valerylene base, 3-pentynyl;Substituted-phenyl can be addressed further under as (1) 2-fluorophenyl, 3-fluorine Phenyl, 4-fluorophenyl, 2-chlorphenyl, 3-chlorphenyl, 4-chlorphenyl, 2-bromophenyl, 3-bromophenyl, 4-bromophenyl, 2-iodophenyl, 3-iodophenyl, 4-iodophenyl (2) 2-tolyl, 3-tolyl, 4-tolyl;(3) 2-anisyl, 3-anisyl, 4-first Oxygen phenyl, 2,3-dimethoxy phenyl, 2,4-dimethoxy phenyl, 2,5-dimethoxy phenyl, 2,6-dimethoxy phenyl, 3,4,5-front threes Oxygen phenyl;(4) 2-acetyl phenyl, 3-acetyl phenyl, 4-acetyl phenyl, 2-propionylphenyl, 3-propionylphenyl, 4-propionylphenyl, 2-butyryl phenyl, 3-butyryl phenyl, 4-butyryl phenyl, 2-valeryl phenyl, 3-valeryl phenyl, 4-valeryl phenyl;(5) 2-Nitrobenzol Base, 3-nitrobenzophenone, 4-nitrobenzophenone, 2-aminophenyl, 3-aminophenyl, 4-aminophenyl, 2-hydroxy phenyl, 3-hydroxy benzenes Base, 4-hydroxy phenyl, 2-carboxyl phenyl, 3-carboxyl phenyl, 4-carboxyl phenyl;Substituted benzyl can be addressed further under as (1) 2-fluorine Benzyl, 3-luorobenzyl, 4-luorobenzyl, 2-chlorobenzyl, 3-chlorobenzyl, 4-chlorobenzyl, 2-bromobenzyl, 3-bromobenzyl, 4-bromobenzyl, 2-iodine benzyl, 3-iodine benzyl, 4-iodine benzyl;(2) 2-methyl-benzyl, 3-methyl-benzyl, 4-methyl-benzyl;(3) 2-methoxybenzyl, 3-methoxybenzyl, 4-methoxybenzyl, 2,3-veratryl, 2,4-veratryl, 2,5-veratryl, 2,6-dimethoxy Benzyl, 3,4,5-trimethoxy benzyls;(4) 2-acetyl benzyl, 3-acetyl benzyl, 4-acetyl benzyl, 2-propionyl benzyl, 3-propionyl benzyl Base, 4-propionyl benzyl, 2-butyryl benzyl, 3-butyryl benzyl, 4-butyryl benzyl, 2-valeryl benzyl, 3-valeryl benzyl, 4-valeryl benzyl Base;(5) 2-nitrobenzyl, 3-nitrobenzyl, 4-nitrobenzyl, 2-aminobenzyl, 3-aminobenzyl, 4-aminobenzyl, 2-hydroxyl Base benzyl, 3-hydroxybenzyl, 4-hydroxybenzyl, 2-carboxybenzyl, 3-carboxybenzyl, 4-carboxybenzyl.
R2Structure representation is: H, COOR6, CONR6R7, (CH2)nXR6(wherein, n=1~8), XR6.X is O, NH, NR7, S. Wherein, R6、R7Can be expressed as: represent hydrogen, substituted or non-substituted straight chain, side chain or ring-type alkyl, phenyl, benzyl,Wherein m=1~8,1-naphthyl, 2-naphthyl, furan or pyranoid form five, hexa-atomic sugar Base or replace glycosyl, or 2~5 by different way (such as: 1,2-, Isosorbide-5-Nitrae-, 1,6-) glucosyl group that connects or replace glucose Base.Above-mentioned straight chain, side chain or ring-type alkyl can be addressed further under as (1) C1~C10Alkyl: methyl, ethyl, propyl group, isopropyl Base, normal-butyl, isobutyl group, the tert-butyl group, sec-butyl, amyl group, neopentyl, hexyl, heptyl, octyl group;(2)C3~C10Cycloalkyl: ring Propyl group, cyclobutyl, cyclopenta, cyclohexyl;(3)C3~C10Thiazolinyl: pi-allyl, cyclobutenyl, crotyl, pentenyl, 2-amylene Base, 3-pentenyl;(4)C3~C10Alkynyl: propinyl, butynyl, 2-butyne base, pentynyl, valerylene base, 3-pentynyl;Take Can be expressed as phenyl: (1) 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2-chlorphenyl, 3-chlorphenyl, 4-chlorphenyl, 2-bromine Phenyl, 3-bromophenyl, 4-bromophenyl, 2-iodophenyl, 3-iodophenyl, 4-iodophenyl;(2) 2-tolyl, 3-tolyl, 4-toluene Base, 2,3-xylyl, 2,4-xylyl, 2,5-xylyl, 2,6-xylyl;(3) 2-anisyl, 3-methoxy benzene Base, 4-anisyl, 2,3-dimethoxy phenyl, 2,4-dimethoxy phenyl, 2,5-dimethoxy phenyl, 2,6-dimethoxy phenyl, 3, 4,5-2,4,5-trimethoxyphenyls;(4) 2-acetyl phenyl, 3-acetyl phenyl, 4-acetyl phenyl, 2-propionylphenyl, 3-propionylphenyl, 4-third Acyl phenyl, 2-butyryl phenyl, 3-butyryl phenyl, 4-butyryl phenyl, 2-valeryl phenyl, 3-valeryl phenyl, 4-valeryl phenyl;(5) 2-nitrobenzophenone, 3-nitrobenzophenone, 4-nitrobenzophenone, 2-aminophenyl, 3-aminophenyl, 4-aminophenyl, 2-hydroxy phenyl, 3-hydroxy phenyl, 4-hydroxy phenyl, 2-carboxyl phenyl, 3-carboxyl phenyl, 4-carboxyl phenyl;Substituted benzyl can be addressed further under For: (1) 2-luorobenzyl, 3-luorobenzyl, 4-luorobenzyl, 2-chlorobenzyl, 3-chlorobenzyl, 4-chlorobenzyl, 2-bromobenzyl, 3-bromobenzyl Base, 4-bromobenzyl, 2-iodine benzyl, 3-iodine benzyl, 4-iodine benzyl;(2) 2-methyl-benzyl, 3-methyl-benzyl, 4-methyl-benzyl, 2, 3-dimethyl benzyl, 2,4-dimethyl benzyl, 2,5-dimethyl benzyl, 2,6-dimethyl benzyl;(3) 2-methoxybenzyl, 3-first Oxygen benzyl, 4-methoxybenzyl, 2,3-veratryl, 2,4-veratryl, 2,5-veratryl, 2,6-dimethoxy benzyl Base, 3,4,5-trimethoxy benzyls;(4) 2-acetyl benzyl, 3-acetyl benzyl, 4-acetyl benzyl, 2-propionyl benzyl, 3-propionyl benzyl Base, 4-propionyl benzyl, 2-butyryl benzyl, 3-butyryl benzyl, 4-butyryl benzyl, 2-valeryl benzyl, 3-valeryl benzyl, 4-valeryl benzyl Base;(5) 2-nitrobenzyl, 3-nitrobenzyl, 4-nitrobenzyl, 2-aminobenzyl, 3-aminobenzyl, 4-aminobenzyl, 2-hydroxyl Base benzyl, 3-hydroxybenzyl, 4-hydroxybenzyl, 2-carboxybenzyl, 3-carboxybenzyl, 4-carboxybenzyl.
R3Structure representation is: H, substituted or non-substituted straight chain, side chain or ring-type alkyl, phenyl, benzyl, Wherein m=1~8.Above-mentioned straight chain, side chain or ring-type alkyl can tables further State as (1) C1~C10Alkyl: methyl, ethyl, propyl group, isopropyl, normal-butyl, isobutyl group, the tert-butyl group, sec-butyl, amyl group, new Amyl group, hexyl, heptyl, octyl group;(2)C3~C10Cycloalkyl: cyclopropyl, cyclobutyl, cyclopenta, cyclohexyl;(3)C3~C10Alkene Base: pi-allyl, cyclobutenyl, crotyl, pentenyl, pentenyl, 3-pentenyl;(4)C3~C10Alkynyl: propinyl, butine Base, 2-butyne base, pentynyl, valerylene base, 3-pentynyl.
Alkali can be potassium tert-butoxide (sodium), Sodium ethylate (potassium), Feldalat NM (potassium), triethylamine, potassium carbonate, sodium carbonate, cesium carbonate, Calcium hydride, sodium hydride.It is preferably potassium tert-butoxide.
Organic solvent is in acetone, butanone, the alcohol of C1-C4, acetonitrile, oxolane, DMF or DMSO and above several are molten The mixed solvent of agent composition is carried out.It is preferably DMF.
(2) the compound IV prepared in step 1 is passed through reduction reaction again, then in the ethyl acetate solution of hydrogen chloride Acidifying obtains 2-amino-gamma-butyrolacton hydrochlorate (I).
In step 2, reducing agent is 5% or 10% palladium carbon;Raney's nickel;Sodium borohydride (potassium).
In step 2, the palladium carbon of reactant IV and 5% or 10% and the mass ratio of Raney's nickel be: 20~5: 1, is preferably 10∶1;Reactant IV with sodium borohydride (potassium) ratio is: 1: 1~10.
In step 2, reaction is in acetone, butanone, the alcohol of C1-C4, acetonitrile, oxolane and above several solvents forms Mixed solvent in carry out.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is described in further detail, its objective is to be better understood on this Bright substantive distinguishing features, therefore the cited case is not construed as the restriction to invention protection domain of the present invention.
Embodiment 1
In 500ml single port bottle, being sequentially added into gamma-butyrolacton 10g, nitrous acid straight butyl 13.2g, after DMF150ml.Cooling To-30 DEG C, it is slowly added to potassium tert-butoxide 19.55g in batches, keeps temperature less than-10 DEG C to reaction completely.Tlc detects reaction The reaction of raw material gamma-butyrolacton completely, adds 10ml water and 10ml acetic acid cancellation reaction, and decompression is distilled off major part solvent, its Middle DMF recoverable.After adding 100ml water, ethyl acetate aqueous layer extracted 3 times, washing once, is dried and is spin-dried for.EA recrystallization, Obtain product 10.3g, yield 75%.
1HNMR (300M, DMSO): 12.65 (s, 1H, OH), 4.44-4.49 (t, 2H, OCH2), 2.93-2.98 (t, 2H, CH2)
Embodiment 2
In 100ml single port bottle, it is sequentially added into 2g 2-(oxyimino)-gamma-butyrolacton, 0.2g10% wet palladium carbon, 30ml Methanol and 3ml glacial acetic acid, react 4h, temperature 40 DEG C in nitrogen atmosphere.Completely, suction filtered through kieselguhr, palladium carbon can return in tlc monitoring reaction Receive.Decompression is distilled off solvent and obtains water white transparency oily thing, is added thereto to 100ml hydrogen chloride/ethyl acetate saturated solution, Stirring 0.5h, sucking filtration, it is dried.Obtain product 2.3g, productivity 96%.
1HNMR (300M, D2O): 2.40-2.81 (m, 2H, CH2), 3.68-3.89 (m, 1H, CHCOO), 4.33-4.61 (m, 2H, OCH2)。

Claims (11)

  1. The preparation method of 1.2-(oxyimino)-gamma-butyrolacton (IV): reacted by compound II and compound III, generationization Compound IV.
    Wherein
    R1Structure representation is: H, substituted or non-substituted straight chain, side chain or ring-type alkyl, phenyl, benzyl, Wherein m=1~8.Above-mentioned straight chain, side chain or ring-type alkyl can be addressed further under as (1) C1 ~C10Alkyl: methyl, ethyl, propyl group, isopropyl, normal-butyl, isobutyl group, the tert-butyl group, sec-butyl, amyl group, neopentyl, hexyl, Heptyl, octyl group;(2)C3~C10Cycloalkyl: cyclopropyl, cyclobutyl, cyclopenta, cyclohexyl;(3)C3~C10Thiazolinyl: pi-allyl, fourth Thiazolinyl, crotyl, pentenyl, pentenyl, 3-pentenyl;(4)C3~C10Alkynyl: propinyl, butynyl, 2-butyne base, Pentynyl, valerylene base, 3-pentynyl;Substituted-phenyl can be addressed further under as (1) 2-fluorophenyl, 3-fluorophenyl, 4-fluorobenzene Base, 2-chlorphenyl, 3-chlorphenyl, 4-chlorphenyl, 2-bromophenyl, 3-bromophenyl, 4-bromophenyl, 2-iodophenyl, 3-iodophenyl, 4- Iodophenyl (2) 2-tolyl, 3-tolyl, 4-tolyl;(3) 2-anisyl, 3-anisyl, 4-anisyl, 2,3- Dimethoxy phenyl, 2,4-dimethoxy phenyl, 2,5-dimethoxy phenyl, 2,6-dimethoxy phenyl, 3,4,5-2,4,5-trimethoxyphenyls;(4) 2-acetyl phenyl, 3-acetyl phenyl, 4-acetyl phenyl, 2-propionylphenyl, 3-propionylphenyl, 4-propionylphenyl, 2-butyryl phenyl, 3-butyryl phenyl, 4-butyryl phenyl, 2-valeryl phenyl, 3-valeryl phenyl, 4-valeryl phenyl;(5) 2-nitrobenzophenone, 3-Nitrobenzol Base, 4-nitrobenzophenone, 2-aminophenyl, 3-aminophenyl, 4-aminophenyl, 2-hydroxy phenyl, 3-hydroxy phenyl, 4-hydroxy benzenes Base, 2-carboxyl phenyl, 3-carboxyl phenyl, 4-carboxyl phenyl;Substituted benzyl can be addressed further under as (1) 2-luorobenzyl, 3-fluorine benzyl Base, 4-luorobenzyl, 2-chlorobenzyl, 3-chlorobenzyl, 4-chlorobenzyl, 2-bromobenzyl, 3-bromobenzyl, 4-bromobenzyl, 2-iodine benzyl, 3- Iodine benzyl, 4-iodine benzyl;(2) 2-methyl-benzyl, 3-methyl-benzyl, 4-methyl-benzyl;(3) 2-methoxybenzyl, 3-methoxybenzyl, 4-methoxybenzyl, 2,3-veratryl, 2,4-veratryl, 2,5-veratryl, 2,6-veratryl, 3,4,5- Trimethoxy benzyl;(4) 2-acetyl benzyl, 3-acetyl benzyl, 4-acetyl benzyl, 2-propionyl benzyl, 3-propionyl benzyl, 4-propionyl benzyl Base, 2-butyryl benzyl, 3-butyryl benzyl, 4-butyryl benzyl, 2-valeryl benzyl, 3-valeryl benzyl, 4-valeryl benzyl;(5) 2-nitre Base benzyl, 3-nitrobenzyl, 4-nitrobenzyl, 2-aminobenzyl, 3-aminobenzyl, 4-aminobenzyl, 2-hydroxybenzyl, 3-hydroxyl Base benzyl, 4-hydroxybenzyl, 2-carboxybenzyl, 3-carboxybenzyl, 4-carboxybenzyl.
    R2Structure representation is: H, COOR6, CONR6R7, (CH2)nXR6(wherein, n=1~8), XR6.X is O, NH, NR7, S.Wherein, R6、R7Can be expressed as: represent hydrogen, substituted or non-substituted straight chain, side chain or ring-type alkyl, phenyl, benzyl,Wherein m=1~8,1-naphthyl, 2-naphthyl, furan or pyranoid form five, hexa-atomic sugar Base or replace glycosyl, or 2~5 by different way (such as: 1,2-, Isosorbide-5-Nitrae-, 1,6-) glucosyl group that connects or replace glucose Base.Above-mentioned straight chain, side chain or ring-type alkyl can be addressed further under as (1) C1~C10Alkyl: methyl, ethyl, propyl group, isopropyl Base, normal-butyl, isobutyl group, the tert-butyl group, sec-butyl, amyl group, neopentyl, hexyl, heptyl, octyl group;(2)C3~C10Cycloalkyl: ring Propyl group, cyclobutyl, cyclopenta, cyclohexyl;(3)C3~C10Thiazolinyl: pi-allyl, cyclobutenyl, crotyl, pentenyl, 2-amylene Base, 3-pentenyl;(4)C3~C10Alkynyl: propinyl, butynyl, 2-butyne base, pentynyl, valerylene base, 3-pentynyl;Take Can be expressed as phenyl: (1) 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2-chlorphenyl, 3-chlorphenyl, 4-chlorphenyl, 2-bromine Phenyl, 3-bromophenyl, 4-bromophenyl, 2-iodophenyl, 3-iodophenyl, 4-iodophenyl;(2) 2-tolyl, 3-tolyl, 4-toluene Base, 2,3-xylyl, 2,4-xylyl, 2,5-xylyl, 2,6-xylyl;(3) 2-anisyl, 3-methoxy benzene Base, 4-anisyl, 2,3-dimethoxy phenyl, 2,4-dimethoxy phenyl, 2,5-dimethoxy phenyl, 2,6-dimethoxy phenyl, 3, 4,5-2,4,5-trimethoxyphenyls;(4) 2-acetyl phenyl, 3-acetyl phenyl, 4-acetyl phenyl, 2-propionylphenyl, 3-propionylphenyl, 4-third Acyl phenyl, 2-butyryl phenyl, 3-butyryl phenyl, 4-butyryl phenyl, 2-valeryl phenyl, 3-valeryl phenyl, 4-valeryl phenyl;(5) 2-nitrobenzophenone, 3-nitrobenzophenone, 4-nitrobenzophenone, 2-aminophenyl, 3-aminophenyl, 4-aminophenyl, 2-hydroxy phenyl, 3-hydroxy phenyl, 4-hydroxy phenyl, 2-carboxyl phenyl, 3-carboxyl phenyl, 4-carboxyl phenyl;Substituted benzyl can be addressed further under For: (1) 2-luorobenzyl, 3-luorobenzyl, 4-luorobenzyl, 2-chlorobenzyl, 3-chlorobenzyl, 4-chlorobenzyl, 2-bromobenzyl, 3-bromobenzyl Base, 4-bromobenzyl, 2-iodine benzyl, 3-iodine benzyl, 4-iodine benzyl;(2) 2-methyl-benzyl, 3-methyl-benzyl, 4-methyl-benzyl, 2, 3-dimethyl benzyl, 2,4-dimethyl benzyl, 2,5-dimethyl benzyl, 2,6-dimethyl benzyl;(3) 2-methoxybenzyl, 3-first Oxygen benzyl, 4-methoxybenzyl, 2,3-veratryl, 2,4-veratryl, 2,5-veratryl, 2,6-dimethoxy benzyl Base, 3,4,5-trimethoxy benzyls;(4) 2-acetyl benzyl, 3-acetyl benzyl, 4-acetyl benzyl, 2-propionyl benzyl, 3-propionyl benzyl Base, 4-propionyl benzyl, 2-butyryl benzyl, 3-butyryl benzyl, 4-butyryl benzyl, 2-valeryl benzyl, 3-valeryl benzyl, 4-valeryl benzyl Base;(5) 2-nitrobenzyl, 3-nitrobenzyl, 4-nitrobenzyl, 2-aminobenzyl, 3-aminobenzyl, 4-aminobenzyl, 2-hydroxyl Base benzyl, 3-hydroxybenzyl, 4-hydroxybenzyl, 2-carboxybenzyl, 3-carboxybenzyl, 4-carboxybenzyl.
    R3Structure representation is: H, substituted or non-substituted straight chain, side chain or ring-type alkyl, phenyl, benzyl, Wherein m=1~8.Above-mentioned straight chain, side chain or ring-type alkyl can be addressed further under as (1) C1 ~C10Alkyl: methyl, ethyl, propyl group, isopropyl, normal-butyl, isobutyl group, the tert-butyl group, sec-butyl, amyl group, neopentyl, hexyl, Heptyl, octyl group;(2)C3~C10Cycloalkyl: cyclopropyl, cyclobutyl, cyclopenta, cyclohexyl;(3)C3~C10Thiazolinyl: pi-allyl, fourth Thiazolinyl, crotyl, pentenyl, pentenyl, 3-pentenyl;(4)C3~C10Alkynyl: propinyl, butynyl, 2-butyne base, Pentynyl, valerylene base, 3-pentynyl.
  2. 2. the preparation method described in claim 1, wherein the mol ratio of reactant II and reactant III is 1: 0.5~1: 1.5.
  3. 3. the preparation method described in claim 1, alkali can be potassium tert-butoxide (sodium), Sodium ethylate (potassium), Feldalat NM (potassium), three second Amine, potassium carbonate, sodium carbonate, cesium carbonate, calcium hydride, sodium hydride.
  4. 4. the preparation method described in claim 1, the mol ratio of reactant II and alkali is 1: 0.5~1: 2.5.
  5. 5. the preparation method described in claim 1, react acetone, butanone, the alcohol of C1-C4, acetonitrile, oxolane, DMF or Carry out in DMSO and in the mixed solvent of above several solvents composition.
  6. 6. the preparation method described in claim 1, reaction temperature therein is-70 DEG C~25 DEG C.
  7. The preparation method of 7.2-amino-gamma-butyrolacton hydrochlorate (I):
    Carried out reduction reaction and acidifying by compound IV, generate compound I.
  8. 8. the preparation method described in claim 7, reducing agent is the palladium carbon of 5% or 10%;Raney's nickel;Sodium borohydride (potassium).
  9. 9. the preparation method described in claim 7, the dry palladium carbon of reactant IV and 5% or 10% and the mass ratio of Raney's nickel For: 20~5: 1;Reactant IV with sodium borohydride (potassium) ratio is: 1: 1~10.
  10. 10. the preparation method described in claim 9, reaction in acetone, butanone, the alcohol of C1-C4, acetonitrile, oxolane and The mixed solvent of above several solvents composition is carried out.
  11. Preparation method described in 11. claim 7, reaction temperature therein is 0 DEG C~80 DEG C.
CN201610268551.5A 2016-04-22 2016-04-22 Synthesis method of 2-amino-gamma-butyrolactone hydrochloride Pending CN105906591A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610268551.5A CN105906591A (en) 2016-04-22 2016-04-22 Synthesis method of 2-amino-gamma-butyrolactone hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610268551.5A CN105906591A (en) 2016-04-22 2016-04-22 Synthesis method of 2-amino-gamma-butyrolactone hydrochloride

Publications (1)

Publication Number Publication Date
CN105906591A true CN105906591A (en) 2016-08-31

Family

ID=56751878

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610268551.5A Pending CN105906591A (en) 2016-04-22 2016-04-22 Synthesis method of 2-amino-gamma-butyrolactone hydrochloride

Country Status (1)

Country Link
CN (1) CN105906591A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109232644A (en) * 2018-09-30 2019-01-18 武汉工程大学 The synthetic method of glufosinate-ammonium
US11827627B2 (en) 2021-06-04 2023-11-28 Vertex Pharmaceuticals Incorporated N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
US11834441B2 (en) 2019-12-06 2023-12-05 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411925A (en) * 1980-01-21 1983-10-25 Pfizer Inc. Branched amides of L-aspartyl-d-amino acid dipeptides
CN102438980A (en) * 2009-02-05 2012-05-02 巴斯夫欧洲公司 Method for producing 2-halogenomethylphenyl acetic acid derivatives
CN103282355A (en) * 2011-01-06 2013-09-04 住友化学株式会社 Method for producing alpha -mino-gamma-butyrolactone

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411925A (en) * 1980-01-21 1983-10-25 Pfizer Inc. Branched amides of L-aspartyl-d-amino acid dipeptides
CN102438980A (en) * 2009-02-05 2012-05-02 巴斯夫欧洲公司 Method for producing 2-halogenomethylphenyl acetic acid derivatives
CN103282355A (en) * 2011-01-06 2013-09-04 住友化学株式会社 Method for producing alpha -mino-gamma-butyrolactone

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
H.R. SNYDER等: "A Convenient Synthesis of dl-Methionine", 《J. CHEM. AM. SOC.》 *
LATHA G. NAIR等: "A Facile and Efficient Synthesis of 3,3-Dimethyl Isopropylidene Proline From (+)-3-Carene", 《J. ORG. CHEM.》 *
MICHAEL G. HOFFMANN等: "A novel and convenient route to L-homoserine lactones and L-phosphinothricin from L-aspartic acid", 《TETRAHEDRON LETTERS》 *
YUKI KONDO等: "Synthesis and Seed Germination Stimulating Activity of Some Imino Analogs of Strigolactones", 《BIOSCI. BIOTECHNOL. BIOCHEM.》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109232644A (en) * 2018-09-30 2019-01-18 武汉工程大学 The synthetic method of glufosinate-ammonium
US11834441B2 (en) 2019-12-06 2023-12-05 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
US11919887B2 (en) 2019-12-06 2024-03-05 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
US11827627B2 (en) 2021-06-04 2023-11-28 Vertex Pharmaceuticals Incorporated N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels

Similar Documents

Publication Publication Date Title
Vijesh et al. Hantzsch reaction: synthesis and characterization of some new 1, 4-dihydropyridine derivatives as potent antimicrobial and antioxidant agents
CA1116622A (en) Iodopropargyl derivatives their use and preparation
KR960005155B1 (en) Aminomethyl-heterocycles
CN105906591A (en) Synthesis method of 2-amino-gamma-butyrolactone hydrochloride
CN103724353B (en) The improvement synthetic method of penoxsuam
DE19507522A1 (en) Prodn. of 3,4-di:hydro-isoquinoline or deriv.
CN107674044A (en) A kind of method using carbon dioxide, amine and aryldiazonium acetic acid esters synthesis of carbamates
Liu et al. The discovery of HNPC‐A3066: a novel strobilurin acaricide
CN104302629B (en) The pyrimidine salicylic acid compounds of weeding activity, its preparation method and the purposes as weedicide thereof
CN101270062B (en) Methylene technique for producing acetochlor
CN102993054B (en) Benzamide derivative and preparation method and application thereof
CN112209894B (en) 5-aryl substituted 2-aminobenzoxazole derivative, preparation method and application thereof
EP0278311B1 (en) 2-aminomethyl tetrahydrofuranes
CN111943821B (en) Synthesis method of (13 cis, 15 trans) -octadecadienal
Valli et al. Anticholinesterasic, nematostatic and anthelmintic activities of pyridinic and pyrazinic compounds
CN102993105A (en) 1-methyl-2, 4-quinazoline diketone derivative and preparation method and application thereof
EP0284952A2 (en) Substituted propylamines
CN100409748C (en) Substituted phenyl-isoxazole herbicide
EP0289913A2 (en) Parasiticidal agent based on substituted aminomethyl heterocycles
CN103570672A (en) Benzoyl hydrazine compound containing thiophene ring, and preparation method and application of compound
CN103333101B (en) Pyridyl sulfoximine compound and preparation method thereof
CN112645885B (en) Iminopyridazine derivative, preparation method and application thereof, and pesticide
RU2816572C1 (en) Method of producing r-n-[[3-[(dimethylamino)carbonyl]pyridin-2-yl]sulphonyl]carbamates, in which substituent r is methyl or ethyl
CN109400588B (en) Fluorine-containing triazole quinoxaline bactericide, preparation method and application thereof
CN111171022B (en) Synthesis method of 1-hydroxy-pyrrolo [2,3-c ] piperidine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160831

WD01 Invention patent application deemed withdrawn after publication